THIOGENESIS THERAPEUTICS COR (TTI.CA) Stock Balance Sheet
TSX-V:TTI • CA88410L1022
Current stock price
0.46 CAD
+0.02 (+4.55%)
Last:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.50M | 3.85M | 7.08M | N/A | N/A | |||
| Receivables | 68.10K | 87.90K | 85.30K | N/A | N/A | |||
| Other Current Assets | 54.90K | 47.60K | 81.40K | N/A | N/A | |||
| Total Current Assets | 3.63M | 3.98M | 7.24M | N/A | N/A | |||
| Non-Current Assets | ||||||||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| TOTAL ASSETS | 3.63M | 3.98M | 7.24M | N/A | N/A | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accounts Payable | 1.47M | 557.90K | 1.71M | N/A | N/A | |||
| Total Current Liabilities | 1.47M | 557.90K | 1.71M | N/A | N/A | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| TOTAL LIABILITIES | 1.47M | 557.90K | 1.71M | N/A | N/A | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -17.68M | -12.67M | -9.47M | N/A | N/A | |||
| Common Shares | 19.91M | 16.14M | 15.01M | N/A | N/A | |||
| Other Shareholders' Equity | -77.30K | -46.00K | -14.70K | N/A | N/A | |||
| Shares Outstanding | 51.84M | 46.02M | 44.57M | 38.86B | 12.00B | |||
| Tangible Book Value per Share | 0.04 | 0.07 | 0.12 | 0.00 | 0.00 | |||
| Total Shareholders' Equity | 2.15M | 3.43M | 5.53M | N/A | N/A | |||
| TOTAL LIABILITIES AND EQUITY | 3.63M | 3.98M | 7.24M | N/A | N/A | |||
| Statistics | ||||||||
| Current Ratio | 2.46 | 7.14 | 4.23 | N/A | N/A | |||
| Return On Assets (ROA) | -188.16% | -78.97% | -69.90% | N/A | N/A | |||
| Return On Equity (ROE) | -316.78% | -91.83% | -91.55% | N/A | N/A | |||
All data in CAD , ROIC based on taxRate of 0.28